The hardest part is no longer getting the numbers. It’s deciding what to do with them. The post Our AI Has an Invisible Footprint — Let’s see How to Measure It appeared first on Towards Data Science. Read More

A hands-on guide to detecting behavioral anomalies from an agent’s evolving execution history The post Let Decision Models Watch Your Agents appeared first on Towards Data Science. Read More

Nature Medicine, Published online: 02 November 2026; doi:10.1038/s41591-026-04739-2 In the STOP-V1 and STOP-V2 trials, povorcitinib (an oral JAK1 inhibitor) was superior to placebo in improvement in F-VASI75 score in individuals with nonsegmental vitiligo. Read More

Nature Medicine, Published online: 02 November 2026; doi:10.1038/s41591-026-04710-1 In the phase 2 UNICORN trial, a short course of neoadjuvant botensilimab and balstilimab achieved the primary endpoint of pathological major response rate in patients with pMMR or dMMR colon cancer. Read More

Nature Medicine, Published online: 02 November 2026; doi:10.1038/s41591-026-04729-4 Analyses of the Global Burden of Disease study reported 887,000 new cases and 369,000 deaths from cervical cancer worldwide in 2023, which are forecasted to rise by 2050. Read More